Sci Transl Med:MECP2复制影响免疫系统以及大脑发育

2013-05-06 Beyond 生物谷

1999年,Huda Zoghbi博士和他的同事在贝勒医学院确定了Rett综合征(一种在出生后开始的神经系统疾病,)的遗传原因即MECP2基因突变。MeCP2蛋白质与基因太少造成女孩逐渐失去讲话等许多认知功能。 2005年,其他研究人员发现硬币的另一面--MECP2复制综合症。这一关键蛋白质太多会导致其他神经系统的问题,主要发生在男性婴儿上,能影响他们的认知和神经系统的发育。然而,这些男孩有另一

1999年,Huda Zoghbi博士和他的同事在贝勒医学院确定了Rett综合征(一种在出生后开始的神经系统疾病,)的遗传原因即MECP2基因突变。MeCP2蛋白质与基因太少造成女孩逐渐失去讲话等许多认知功能。

2005年,其他研究人员发现硬币的另一面--MECP2复制综合症。这一关键蛋白质太多会导致其他神经系统的问题,主要发生在男性婴儿上,能影响他们的认知和神经系统的发育。然而,这些男孩有另一个令人担忧的问题。他们往往患上毁灭性的感染,往往是肺炎。

在12月5日发表在Science Translational Medicine杂志上的研究报告中,研究人员确定了这些感染的罪魁祸首。同样,研究还证实了过量的MeCP2是危险的。

患有MeCP2复制综合征的儿童和老鼠的免疫系统缺少重要组成部分,细胞因子γ干扰素。 γ-干扰素是免疫系统对抗入侵病毒和细菌的一个重要工具。用患有疾病的人来源的细胞以及小鼠体内的研究显示,两个群体都缺乏型辅助性T细胞(Th1细胞),后者是产生γ干扰素的关键。

他们的实验室研究表明MeCP2能抑制辅助性T细胞γ-干扰素的分泌,导致局部免疫缺陷。
为了证实这一观点,研究人员发现老鼠无法抵御利什曼原虫的感染。然而,他们能够击退黑曲霉真菌感染,其中就涉及到2型辅助性T细胞的免疫反应。
 
Corry指出,有可能一个正常运作免疫系统的缺乏会促发这些婴儿神经性疾病。这项研究中,临床研究和基础研究相结合,利用小鼠模型研究MeCP2患者的免疫反应,发现MECP2启发感染的关键因素。下一步研究人员要积极找出感染这些孩子的病原体,以及如何最好地治疗他们。

doi:10.1126/scitranslmed.3004430
PMC:
PMID:

Overexpression of Methyl-CpG Binding Protein 2 Impairs TH1 Responses.

Tianshu Yang, Melissa B. Ramocki, Jeffrey L. Neul, Wen Lu, Luz Roberts, John Knight, Christopher S. Ward, Huda Y. Zoghbi, Farrah Kheradmand, and David B. Corry.

The DNA binding protein methyl-CpG binding protein 2 (MeCP2) critically influences neuronal and brain function by modulating gene expression, and children with overexpression of the MECP2 gene exhibit postnatal neurological syndromes. We demonstrate that some children with MECP2 duplication also display variable immunological abnormalities that include reductions in memory T and B cells and natural killer cells and immunoglobulin assay responses. Moreover, whereas mice with MeCP2 overexpression were unable to control infection with the intra-macrophage parasite Leishmania major and secrete interferon-γ (IFN-γ) from involved lymph nodes, they were able to control airway fungal infection by Aspergillus niger and mount protective T helper cell type 2 (TH2)–dependent allergic responses. Relative to normal T cells, TH cells from children and mice with MECP2 duplication displayed similar impairments in IFN-γ secretion and TH1 responses that were due to both MeCP2-dependent suppression of IFN-γ transcription and sequestration of the IFN-γ locus as assessed by chromatin immunoprecipitation assay. Thus, overexpressed MeCP2 aberrantly suppresses IFN-γ secretion from TH cells, potentially leading to a partially immunodeficient state. Our findings establish a rational basis for identifying, treating, and preventing infectious complications potentially affecting children with MECP2 duplication.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-08-12 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2014-02-04 wodejia-dayu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-05-08 neurowu
  7. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1656576, encodeId=0c6e16565e6f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 12 20:56:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042110, encodeId=0f25204211042, content=<a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6504, encryptionId=728c65040e, topicName=ECP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Tue Feb 04 00:56:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678197, encodeId=c27a16e8197f4, content=<a href='/topic/show?id=1e5d1145e8c' target=_blank style='color:#2F92EE;'>#MeCP2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11457, encryptionId=1e5d1145e8c, topicName=MeCP2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri May 24 02:56:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950503, encodeId=b91f1950503b2, content=<a href='/topic/show?id=24aa84e7146' target=_blank style='color:#2F92EE;'>#脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84771, encryptionId=24aa84e7146, topicName=脑发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Sun May 12 14:56:00 CST 2013, time=2013-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067124, encodeId=bda1206e12437, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed May 08 16:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346991, encodeId=0f40134699171, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399510, encodeId=6359139951050, content=<a href='/topic/show?id=abae4388359' target=_blank style='color:#2F92EE;'>#大脑发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43883, encryptionId=abae4388359, topicName=大脑发育)], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/ED2CC9E7989F19A8FE1EC8C4B58CDA69/100, createdBy=cdee2217473, createdName=gj0732, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605947, encodeId=9051160594e1e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-05-08 智智灵药

相关资讯

Kidney Inter:慢性肾病或可改变机体肠道菌群

2012年10月10日 讯 /生物谷BIOON/ --近日,来自加州大学欧文分校的研究者揭示了,慢性肾病可以改变机体肠道细菌菌群的组成,而肠道中细菌的菌群对于机体抵御致病菌及维持微营养平衡至关重要。而在长期效应中,肠道菌群的改变会导致尿毒症毒素、局部炎症及营养失衡的产生。相关研究成果发表在了杂志Kidney International上。 研究者对肾衰竭病人和健康个体的粪便样品进行微生物DNA的

Sleep:揭示调节食欲的激素的作用方式因性别而异

刊登在国际杂志Sleep上的一篇研究报告指出,增加成人的睡眠量可以导致其食物摄取量降低,而且在男性和女性中和食物摄取相关的激素分泌过程也表现出不同。研究者Marie-Pierre St-Onge博士说,在健康正常体重的参与者中,通过限制其睡眠就会限制其代谢风险因子的效应,而且会通过在男、女机体中不同的调节荷尔蒙分泌的方式来影响其食物的摄取量。 研究者针对睡眠对葡萄糖、胰岛素以及瘦素的影响,以及饥

Sci Transl Med:开发出用于研究人类疾病的肺部微芯片装置

2012年11月9日 --刊登在11月7日的国际杂志Science Translation Medicine上的一篇研究报告中,来自哈佛大学的研究者使用活的人体细胞在微芯片中模仿肺部水肿,研究者使用这种肺部芯片模型(lung-on-a-chip)来研究药物的毒性以及开发出新型的疾病疗法。 研究者Donald说,很多制药公司在细胞培养和动物试验上花费了大量时间和金钱,只为开发出新型的疾病疗法或者新

PLoS Pathog:新研究揭示沙门氏菌如何在体内散播

2012年12月6日讯 /生物谷BIOON/ --英国剑桥大学科学家12月6日发表在PLoS Pathogens杂志上的一项研究揭示了细菌在体内扩散的新机制,可能确定了能防止细胞传播感染的靶标。 沙门氏菌是一大威胁公众健康,引起全身性疾病(伤寒和副伤寒),肠胃炎和非伤寒败血症(NTS)的病毒。在自然感染过程中,沙门氏菌通常是通过污染水或食物感染人类,健康人群通过与病毒携带体接触也会感染。目前,沙

Nature:炎症性肠道疾病(IBD)的遗传研究

2012年11月6日--最近,一个国际科学家小组研究发现了炎症性肠道疾病(IBD)的遗传基础。克罗恩氏病和溃疡性结肠炎是炎症性肠道疾病最常见的两种形式。 蒙特利尔心脏研究所与蒙特利尔大学医学副教授John Rioux博士已经确定了71个基因区域与炎性肠道疾病(IBD)发病有关,迄今发现与IBD发病相关的基因总数增加至163个。此外,该研究指出,这些基因区域表现出显著的重叠功效即也与自身免

NEJM:发现治疗克罗恩氏病的潜在新药物疗法

2012年10月19日优特克诺(ustekinumab, 也译作优斯它单抗)是一种能够治疗被称作银屑病的皮肤病的抗体。如今,根据一项最新的研究,来自美国加州大学圣地亚哥分校的研究人员发现它也能降低克罗恩氏病(Crohn's Disease)的破坏性影响。相关研究结果于2012年10月18日刊登在New England Journal of Medicine期刊上。 来自临床试验的结果证实优特克诺